Crescent Capital Consulting’s iShares S&P Mid-Cap 400 Growth ETF IJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3.03M Sell
35,550
-21,798
-38% -$1.83M 0.5% 46
2021
Q3
$4.54M Sell
57,348
-1,528
-3% -$124K 0.83% 29
2021
Q2
$4.76M Sell
58,876
-13,830
-19% -$1.11M 0.89% 31
2021
Q1
$5.7M Sell
72,706
-4,650
-6% -$358K 1.25% 20
2020
Q4
$5.59M Buy
+77,356
New +$5.16M 1.44% 16

Other funds holding IJK

Crescent Capital Consulting's IJK Position: Q4 2021 in Review

Crescent Capital Consulting reduced its iShares S&P Mid-Cap 400 Growth ETF (IJK) stake by 38% in Q4 2021, selling an estimated $1.83M and leaving 35,550 shares worth $3.03M. The position accounts for 0.5% of the portfolio, ranked #46.

Crescent Capital Consulting first reported a position in IJK in Q4 2020 and has held it in 5 quarters since. The position peaked at $5.7M in Q1 2021. 735 funds tracked by Wall St. Rank hold IJK as of Q4 2021.

  • Crescent Capital Consulting held 35,550 shares of iShares S&P Mid-Cap 400 Growth ETF worth $3.03M as of Q4 2021.
  • Crescent Capital Consulting sold 21,798 iShares S&P Mid-Cap 400 Growth ETF shares in Q4 2021, an estimated $1.83M.
  • iShares S&P Mid-Cap 400 Growth ETF made up 0.5% of Crescent Capital Consulting's portfolio in Q4 2021, its #46 holding.
  • Crescent Capital Consulting first reported a position in iShares S&P Mid-Cap 400 Growth ETF in Q4 2020 and has held it in 5 quarters since.
  • Crescent Capital Consulting's iShares S&P Mid-Cap 400 Growth ETF position peaked at $5.7M in Q1 2021.
  • 735 funds tracked by Wall St. Rank held iShares S&P Mid-Cap 400 Growth ETF as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.